Protozoan pathogens
Kinetoplastids
Leishmania and Trypanosoma
       Learning outcomes
After this lecture, you should be able to:
• Discuss the lifecycle of Leishmania and
  the associated disease conditions
• Explain the lifecycle of Trypanosoma and
  the associated disease conditions
                     Leishmania
• Several different species
   –   L.donovani
   –   L. tropica
   –   L. braziliensis
   –   L. mexicana
• Cause different diseases
• Approx 20 different Leishmania species capable
  of infecting humans
• Life cycles differ slightly in tissues affected and
  clinical symptoms
            Global distribution
Global distribution of reported cases of leishmaniasis and
Leishmania/HIV co-infection, 1990-1998 taken from the WHO web site
Lifecycle of Leishmania
                 Different stages
• The parasite has a number of different stages
• Presence of surface LPG molecule protects parasite
  (lipophosphoglycan)
• Promasitgote
   –   Long, slender, free flagellum
   –   Found in the gut of infected sandflies
   –   Transferred during biting (female sandfly)
   –   Initial infective stage
• Amastigote
   – Promastigote loses flagella to become amastigote
   – Infect endothelial cells and reproduce cause cells to rupture,
     induces tissue damage
   – Diagnostic stage for the disease
   – Convert back to promastigotes in sandfly gut
              L. donovani
• Normally associated with viseral leishmaniasis
• Approx 500,000 cases each year mainly in India,
  Bangladesh, Brazil
• Some rodents able to act as a reservoir
• Subvariants chagasi and infantum are found in
  South America and China/Mediterranean
  respectively
• Animal reservoirs include dogs, foxes and
  porcupines
• donovani and infantum transmitted by
  Phlebotomus sandfly, chagasi by the Lutzomyia
  sandfly
Visceral leishmaniasis
• Fairly long incubation period
• Fever, diarrhoea, anaemia                   Taken from the WHO website
• Initial symptoms may resemble malaria
• Enlarged liver, spleen, weight loss
• Pigmented areas of skin develop
• If untreated can lead to death in a matter of
  weeks
• Diagnosed by tissue biopsy to check for
  amastigote parasites
• Can also be diagnosed serologically
                Treatments
• Pentavalent antimonials i.e. stibogluconate
• Highly toxic
• Not very successful
• Recent develops include miltefosine (95%
  effective)
• Need to control host reservoirs
• Protection from sandflies also important i.e.
  repellents, screens
• Vaccines currently researching.
        L. tropica
                                          Taken from Wikipedia. This work is in the public domain in the United
                                          States because it is a work of the United States Federal Government
                                          under the terms of Title 17, Chapter 1, Section 105 of the US Code.
•   Causes cutaneous disease
•   Same lifecycle transmitted by Phlebotomus sandfly
•   Found in Africa, Asia, Mediterranean Europe
•   Reservoir in dogs, foxes
•   mexicana is highly related and occurs in Central America
    transmitted by the Lutzomyia sandfly
•   Incubation period varies 2 weeks to 2 months from bite
•   Lesion appears at site of bite
•   Lesions often self heal without treatment but usually scar
•   Raised area around outside contains replicating
    parasites
   Cutaneous leishmaniasis in Sri
              Lanka
In 2011, 940 cases of CL were reported in Sri
Lanka, caused by L. donovani
    Diagnosis and treatment
• Identify amastigotes from ulcers
• Can also be diagnosed serologically
• Treated using stibogluconate (antimonial)
• Fluconazole and miltefosine are effective
• Protection from sandflies through
  screening and repellents
• Controlling reservoirs of insects
• Hope of developing vaccines??
 L. Braziliensis
• Same lifecycle as others, transmitted by Taken from the WHO website
  Lutzomyia sandfly
• Found in Central and South America
• Causes mucocutaneous Leishmaniasis
• Causes ulcers and also causes the destruction
  of mucous membranes particularly the nose and
  throat
• Often associated with oedema and other
  infection which can cause severe facial
  disfigurement
   Treatment and diagnosis
• Diagnoses serologically or through
  identification of the parasite
• Treated with stibogluconate or
  amphotericin B
• Protective screens and repellents
• Work to develop a vaccine is underway
Trypanosoma
                         Trypanosoma
• Causes two different
  forms of disease
• Trypanosoma brucei
  – vector tsetse fly
  – African
    trypanosomiasis/
    sleeping sickness
• Trypanosoma cruzi
  – Transmitted by
    triatomids
  – American
    trypanosomiasis/
    Chagas disease           Taken from the CDC web site
T. brucei lifecycle (Sleeping sickness)
                          T. brucei
A: Trypanosoma brucei sp. in a thin blood smear stained with Giemsa.
The trypomastigote is beginning to divide; dividing forms are seen in
African trypanosomes, but not in American trypanosomes.
                     T. brucei
• Two subspecies cause distinct disease patterns
  – T. b. gambiense (West African sleeping sickness)
     • No known reservoir
  – T. b. rhodesiense (East African sleeping sickness)
     • A number of animal reservoirs
• more severe disease is caused by rhodesiense
• Major pathogen of livestock both wild and
  domestics animals causes Nagana
• Rare transmission can occur by the following
  – Mother to child infection
     • the trypanosome can cross the placenta and infect the
       foetus, causing prenatal death.
  – Organ transplantation
  – Blood transfusion
        Symptoms of disease
• haemolymphatic stage
  – fever
  – enlarged lymph nodes
  – itching.
• meningoencephalitic stage
  – lethargy
  – tremors
• invasion of the CNS
  –   headaches
  –   sleepiness
  –   abnormal behaviour
  –   loss of consciousness
  –   coma
     Diagnosis and treatment
• microscopic examination tissue samples to identify
  parasites
   – lymph node aspirates, blood, bone marrow, or, in the late stages
     of infection, cerebrospinal fluid, blood smears
   – Identify motile trypanosomes, or fix and stain with Giemsa.
• Antibodies can be used but not commercially available
   – seroconversion occurs with T. b. rhodesiense so limits use of
     AB’s
• acute infections
   – Suramin (rhodes) or pentamidine (gambiense, less toxic drug)
     both these drugs unable to cross blood brain barrier
• Chronic i.e. CNS
   – Melarsoprol (arsenic based, highly toxic)
• As rhodesiense has a shorter incubation treatment often
  required more quickly as disease progresses more
  quickly and is more severe
• Controlling vector with insecticides etc protection from
  vector
T. cruzi lifecycle (Chagas disease)
                           T. cruzi
                     C                              D
C, D: T. cruzi trypomastigotes in thin blood smears stained with Giemsa.
Note the typical C-shape of the trypomastigote that characterises
T. cruzi in fixed blood smears.
              T. cruzi infection
•   Bug bites takes meal then defecates
•   Parasites in faeces, enter wound
•   Eyes are a common point of entry
•   Can also be transmitted congenitally and via blood
    transfusion/transplants
•   Parasites migrate to cardiac muscle, liver brain invade
    cells to replicate which results in cell destruction
•   A number of animal reservoirs
•   Affect South and Central America, some cases in North
    America
•   Associated with poverty and found primarily in rural
    areas
•   Major cause of heart disease in Latin America
                      Symptoms
• Infections can be
   – Asymptomatic
   – Acute
   – Chronic
• Initial symptoms, development of lesion at site of bite,
  development of rash and swelling
• acute infection
   –   fever
   –   chills
   –   myalgia
   –   fatigue
• Chronic infection
   – parasites replicate in liver heart brain etc causing massive tissue
     damage
• Reactivation if immunocompromised can result in high
  mortality rate e.g. AIDS, chemotherapy etc
     Diagnosis and treatment
•   Serological tests available (IgG antibodies used to diagnose
    chronic infection)
•   Microscopic examination of blood, blood smears stained
    with Giemsa, for visualization of parasites during acute
    infection.
•   Limited number of available drugs
•   drugs often have a large number of side effects usually
    effective when given during the acute phase of infection but
    may be helpful for chronic phase as well.
•   Nifurtimox only useful against acute phase
•   Allopurinol and benzimidazole useful against tissue
    parasites
•   Controlling animal reservoirs and vector essential
•   Possible vaccine??
        Revision questions
• Explain the differences in the lifecycles of
  T. brucei and T. cruzi.
• Discuss the different infections caused by
  Leishmania parasites.
         Directed learning
• What is the current status of these
  diseases in Sri Lanka? Please do some
  research and spend some time making
  notes to supplement your lecture slides.
 Suggested reading materials
• Leishmania
  – http://onlinelibrary.wiley.com/doi/10.1038/npg.els.000
    3824/full
  – http://onlinelibrary.wiley.com/doi/10.1038/npg.els.000
    4265/full
• Trypanosomiasis
  – http://onlinelibrary.wiley.com/doi/10.1038/npg.els.000
    4287/full